NEW YORK, Nov. 18 (GenomeWeb News) - NanoInk has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to support the development of its Dip Pen Nanolithography technology for miniaturizing DNA arrays, the company said today.
NanoInk said the grant is the first award of a two-phase $1.3 million award. Phase I SBIR's are generally in the $100,000 range.
The company said the grant is a result of an NIH initiative to facilitate multidisciplinary work in nanotechnology. The DPN process is able to precisely position molecules on a surface, which permits direct-deposition printing of features with nanometer-scale dimensions, according to NanoInk.
The company said it can use the technique to create biomolecule nanoarrays with features that are up to 10,000 times smaller than those produced with conventional microarray technology.